No abstract available
MeSH terms
-
Adult
-
Antirheumatic Agents / administration & dosage
-
Antirheumatic Agents / adverse effects
-
Arthritis, Psoriatic / drug therapy*
-
Certolizumab Pegol* / administration & dosage
-
Certolizumab Pegol* / adverse effects
-
Demyelinating Diseases* / chemically induced
-
Demyelinating Diseases* / diagnosis
-
Demyelinating Diseases* / physiopathology
-
Diagnosis, Differential
-
Glucocorticoids / administration & dosage
-
Humans
-
Male
-
Oculomotor Nerve Diseases* / chemically induced
-
Oculomotor Nerve Diseases* / diagnosis
-
Oculomotor Nerve Diseases* / physiopathology
-
Prednisone / administration & dosage*
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Antirheumatic Agents
-
Glucocorticoids
-
Tumor Necrosis Factor-alpha
-
Certolizumab Pegol
-
Prednisone